YOLFTbeta
Active Biotech AB

Active Biotech AB

ACTI · ST · Healthcare / Biotechnology

3.54SEK+0.02 (+0.71%)

Price History

Full chart

Market Stats

Previous Close3.52
Open3.52
Day Range3.45 – 3.69
52-Week Range3.70 – 13.09
Volume23.92K
Market Cap99.91M
P/E (TTM)0.00
Forward P/E109.89
EPS-1.89
Dividend Yield0.00%
Beta1.34
50-Day Avg4.83
200-Day Avg5.24

About

Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase II clinical trial to treat hematological malignancies; Laquinimod, an immunomodulator for the treatment of severe inflammatory eye diseases, such as non-infectious non anterior uveitis; and Naptumomab estafenatox, a tumor targeting immunotherapy to treat patients with solid tumors. The company has collaboration with Abramson Cancer Center, University of Pennsylvania, MD Anderson Cancer Center, Texas and Stictching-Haemato-Oncologie Volwassenen Netherlands, as well as Stanford Medicine and the Global Ophthalmic Research Center. The company was incorporated in 1983 and is headquartered in Lund, Sweden.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMs. Helen Tuvesson Ph.D.
  • Employees5
  • HeadquartersScheelevägen 22, Lund, Sweden, 223 63, Sweden
  • Websitehttps://www.activebiotech.com

Leadership

  • Ms. Helen Tuvesson Ph.D.President & CEO · b. 1962
  • Mr. Hans KolamChief Financial Officer · b. 1951
  • Dr. Erik Vahtola M.D., Ph.D.Chief Medical Officer · b. 1976

Financials

Income Statement

Currency: SEK2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue280.44M102.26M-3.85M335.00K69.72M9.15M66.36M12.08M53.46M10.77M11.36M234.59M219.09M108.14M2.27M16.27M19.04M20.25M20.05M8.43M6.72M6.22M0000
Growth (%)--63.54%-103.76%+108.71%+20713.13%-86.87%+625.08%-81.80%+342.63%-79.85%+5.42%+1965.81%-6.61%-50.64%-97.91%+618.54%+17.00%+6.32%-0.96%-57.98%-20.18%-7.43%-100.00%---
Cost of Revenue166.84M69.98M200.00K----------009.19M8.91M6.13M0--1.28M1.49M1.68M1.64M1.60M
Gross Profit---4.05M335.00K69.72M9.15M66.36M12.08M53.46M10.77M11.36M234.59M219.09M108.14M2.27M7.09M10.13M14.11M20.05M8.43M6.72M-1.28M-1.49M-1.68M-1.64M-1.60M
Gross Margin--105.20%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%43.55%53.21%69.70%100.00%100.00%100.00%-20.56%----
Operating Expense---345.16M-336.10M-131.13M142.39M190.93M214.77M238.06M230.35M240.32M335.52M382.31M317.17M230.72M185.01M65.26M116.64M49.89M40.71M39.03M48.50M56.39M44.81M38.16M36.00M
Operating Income--341.11M336.44M200.85M-133.24M-124.57M-202.69M-184.60M-219.57M-228.97M-100.92M-163.22M-209.03M-228.46M-177.93M-55.12M-102.53M-29.84M-32.28M-32.31M-49.78M-57.89M-46.48M-39.80M-37.60M
Operating Margin---8866.99%100428.96%288.07%-1455.87%-187.72%-1678.31%-345.33%-2038.38%-2016.25%-43.02%-74.50%-193.28%-10086.53%-1093.25%-289.49%-506.41%-148.83%-383.20%-480.39%-799.71%----
EBITDA--346.55M341.70M204.69M-109.19M-102.62M-202.69M-184.60M-207.23M-217.75M-82.20M-149.51M-192.60M-213.82M-165.83M-45.76M-96.62M-29.46M-31.33M-30.84M-48.52M-56.67M-43.89M-38.30M-36.00M
EBITDA Margin---9008.37%101999.40%293.57%-1193.08%-154.64%-1678.31%-345.33%-1923.80%-1917.51%-35.04%-68.24%-178.09%-9440.18%-1018.91%-240.29%-477.24%-146.93%-371.86%-458.56%-779.42%----
Net Income-33.02M-298.89M-307.60M-174.23M-135.41M-139.18M-207.72M-181.59M-223.98M-221.06M-94.55M-175.01M-212.09M-231.51M-193.53M-59.58M-108.79M-36.88M-36.07M-32.12M-49.88M-58.69M-45.80M-39.40M-37.30M
Net Income Margin-32.29%7769.46%-91820.60%-249.88%-1479.62%-209.74%-1719.95%-339.69%-2079.25%-1946.68%-40.30%-79.88%-196.11%-10221.28%-1189.13%-312.91%-537.36%-183.92%-428.08%-477.58%-801.33%----
R&D271.76M294.56M285.17M284.17M239.66M55.38M46.47M189.75M207.40M212.05M217.26M318.57M375.28M308.02M221.88M176.23M58.25M49.35M39.32M28.47M25.55M34.54M42.82M32.54M26.67M25.20M
R&D as % of Total Revenue96.90%288.05%-7412.79%84826.57%343.72%605.16%70.03%1571.14%387.98%1968.49%1913.17%135.80%171.29%284.82%9796.25%1082.81%305.89%243.76%196.08%337.96%379.91%554.80%----
Interest Expense0038.23M34.71M30.46M20.07M19.23M11.83M10.24M10.70M6.52M14.63M9.57M8.80M7.64M6.87M7.13M7.14M6.97M1.94M87.00K26.00K206.00K238.00K177.00K113.00K
Interest Expense % of Total Revenue0.00%0.00%-993.74%10361.49%43.69%219.30%28.97%97.97%19.16%99.37%57.40%6.24%4.37%8.13%337.44%42.19%37.42%35.27%34.76%22.98%1.29%0.42%----

Balance Sheet

Currency: SEK2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets868.95M747.74M467.50M345.40M312.89M567.86M462.40M489.54M472.95M498.50M503.10M858.52M696.74M767.81M722.52M449.44M412.88M303.81M302.43M66.95M32.16M56.80M51.01M44.05M43.20M70.20M
Total Liabilities222.92M68.96M87.24M55.82M150.59M391.05M402.04M299.97M309.34M309.86M321.34M356.53M356.82M362.40M317.21M268.84M230.32M226.14M214.52M13.17M10.04M10.13M16.49M13.38M11.13M14.60M
Total Equity646.03M678.78M380.27M289.58M162.30M176.81M60.36M189.57M163.61M188.64M181.76M501.99M339.92M405.41M405.31M180.60M182.56M77.68M87.92M53.78M22.11M46.67M34.51M30.67M32.07M55.60M
Cash99.94M125.10M169.15M45.29M210.61M178.43M97.89M138.61M138.74M156.03M131.14M465.17M216.66M376.19M328.45M103.62M77.68M25.15M25.55M59.68M26.21M53.13M41.80M36.22M27.40M65.10M
Total Debt--2.68M4.93M98.47M360.50M358.74M253.93M258.38M255.48M257.23M242.81M236.51M230.94M229.54M222.76M216.28M210.41M204.35M3.25M2.00M986.00K6.04M4.54M3.18M1.74M
Net Debt---166.47M-40.36M-112.14M182.07M260.86M115.31M119.64M99.44M126.09M-222.37M19.85M-145.25M-98.92M119.14M138.60M185.26M178.80M-56.43M-24.21M-52.15M-35.76M-31.67M-24.22M-63.36M

Cash Flow

Currency: SEK2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---291.71M-288.83M-149.65M-192.51M-100.13M-186.70M-159.46M-224.77M-196.32M-46.97M-240.40M-102.25M-267.09M-217.89M-73.16M-46.45M-40.65M-35.81M-32.22M-46.17M-54.85M-45.74M-40.40M-32.40M
Investing Cash Flow-508.61M-1.23M-1.09M-1.77M-15.06M24.97M185.00K6.96M-72.00K-91.00K-527.00K-17.00K-53.00K-1.90M-275.00M275.00M275.00M275.00M-200.00K-200.00K-245.00K0--
Financing Cash Flow-33.99M26.19M188.48M138.63M171.16M-5.37M227.24M152.63M242.14M171.52M381.53M-8.10M261.84M221.25M-6.95M47.22M-6.08M41.05K-205.06M-1.25M73.09M43.76M40.16M31.60M70.10M
Capital Expenditure29.34M30.18M408.00K67.00K68.00K5.23M33.00K91.00K2.85M72.00K91.00K527.00K17.00K53.00K1.90M0000000245.00K0032.40M
Free Cash Flow---292.12M-288.90M-149.71M-197.74M-100.17M-186.79M-162.32M-224.84M-196.41M-47.50M-240.41M-102.30M-268.99M-217.89M-73.16M-46.45M-40.65M-35.81M-32.22M-46.17M-55.09M-45.74M-40.40M-32.40M
FCF to OCF--100.14%100.02%100.05%102.71%100.03%100.05%101.79%100.03%100.05%101.12%100.01%100.05%100.71%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.45%100.00%100.00%100.00%

Earnings

Report DateSep 30, 2003Nov 2, 2005Feb 16, 2006Aug 10, 2006Nov 2, 2006May 4, 2007Nov 8, 2007Apr 24, 2008Aug 6, 2008Nov 14, 2008Feb 12, 2009Apr 23, 2009Aug 6, 2009Nov 5, 2009Feb 11, 2010Apr 22, 2010Aug 11, 2010Oct 27, 2010Feb 10, 2011Apr 28, 2011Aug 11, 2011Nov 3, 2011Feb 16, 2012Apr 26, 2012Aug 10, 2012Nov 9, 2012Feb 14, 2013Apr 25, 2013Aug 7, 2013Nov 7, 2013Feb 13, 2014Apr 24, 2014Aug 7, 2014Nov 5, 2014Feb 11, 2015Apr 23, 2015Aug 7, 2015Nov 6, 2015Feb 18, 2016Apr 28, 2016Aug 11, 2016Nov 11, 2016Feb 16, 2017Apr 27, 2017Aug 10, 2017Nov 9, 2017Feb 15, 2018Apr 26, 2018Aug 9, 2018Nov 14, 2018Feb 14, 2019Apr 25, 2019Aug 8, 2019Nov 14, 2019Feb 6, 2020Apr 23, 2020Aug 6, 2020Nov 5, 2020Feb 11, 2021Apr 22, 2021Aug 5, 2021Nov 4, 2021Feb 10, 2022Apr 21, 2022Aug 4, 2022Nov 3, 2022Feb 9, 2023Apr 26, 2023Aug 24, 2023Nov 9, 2023Feb 8, 2024May 8, 2024Aug 22, 2024Oct 21, 2024Feb 13, 2025May 8, 2025Aug 21, 2025Nov 6, 2025Feb 12, 2026May 7, 2026Aug 20, 2026
EPS Estimate--96.77-96.77-104.34-104.34-108.63-97.42---99.73-30.35---83.00-87.00---78.00-73.00-59.00-90.00--129.0042.00-89.50-140.00-120.50-120.00-110.00--110.00-100.00-70.00-60.00---74.00-------------------------------------------
EPS Actual-39.71-76.57-92.56-75.730.84-109.49-72.42-17.39-15.05-105.80-32.95-19.05-18.41-73.00-92.00-15.10-15.08-74.00-97.00-18.53214.00-115.00-24.61-144.00-21.76-75.000.00-110.00-108.0039.00-19.84-80.00-77.00-76.00-73.00-0.38-0.47-26.00-0.27-0.11-0.10-0.08-0.10-0.10-0.15-0.05-0.38-2.73-0.05-0.05-0.05-0.04-0.03-0.05-0.06-0.07-0.07-0.06-0.03-0.05-0.06-0.05-0.07-0.07-0.07-0.06-0.06-0.04-0.04-0.04-0.04-0.03-0.03-0.01-0.01-0.01-0.01-0.00-0.01-0.00-0.38
Surprise-20.87%4.35%27.42%100.81%-0.79%25.66%---6.09%-8.57%--12.05%-5.75%--5.13%-32.88%-262.71%-27.78%--11.63%-151.81%16.20%100.00%8.71%10.00%135.45%-27.27%23.00%-8.57%-21.67%--64.86%-------------------------------------------
Timing-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market--Pre-marketPre-market--Pre-marketPre-market--After-hoursPre-market-After-hoursAfter-hours-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hours-Pre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap99.91M
Enterprise Value45.11M
Trailing P/E0.00
Forward P/E109.89
PEG Ratio0.13
Price / Sales29.72
Price / Book2.92
EPS-1.89
Book Value1.41
Revenue (TTM)6.22M
Gross Profit (TTM)6.72M
EBITDA-32.60M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-140.56%
Return on Assets-60.37%
Shares Outstanding26.36M
Shares Float20.47M
Beta1.34
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

19981×
59.22Apr 17, 1998
19971×
59.22May 13, 1997
19911×
296.12May 22, 1991

Stock Splits

  • Jun 3, 20261:100
  • Nov 20, 2025765:607
  • Oct 25, 2024423:191
  • Nov 15, 2023680:611
  • Aug 17, 202225:24
  • Dec 30, 202081:68
  • Mar 23, 2018294:221
  • Nov 17, 2016418:411
  • Dec 3, 2014339:320
  • May 18, 2009595:516
  • May 16, 2008853:848
  • Jan 22, 20071793:1750
  • Jun 8, 20051073:1043
  • Jun 6, 19951:10